Real-time enrollment status for this glioblastoma clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT06359379 |
| Recruiting Status | Terminated |
| Condition | Glioblastoma |
| Phase | Clinical Trial |
| Target Enrollment | 54 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Shuttle Pharmaceuticals, Inc. |
| Last Updated on CT.gov | December 18, 2025 (Dec 18, 2025) |
As of March 2, 2026: Clinical trial NCT06359379 is currently terminated participants. This clinical trial study for glioblastoma is not currently accepting new participants at 6 locations across the United States. The study is sponsored by Shuttle Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06359379 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06359379 was last updated Dec 18, 2025 (December 18, 2025). HelloStudys verifies this status automatically.